Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1986 Mar;55(3):231–239. doi: 10.1136/hrt.55.3.231

High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.

B A MacLennan, A McMaster, S W Webb, M M Khan, A A Adgey
PMCID: PMC1232158  PMID: 3954907

Abstract

Streptokinase (1 million international units) was given intravenously over 30 or 60 minutes to 50 patients four hours or less after the onset of acute myocardial infarction. All were aged less than or equal to 70 years and had 4 mm or greater ST segment elevation in anterior or inferior leads. Rapid (mean 95 min) ST segment resolution, which was taken to indicate reperfusion of the myocardium, occurred in 36 (72%) patients. In these 36 the average time from onset of symptoms to peak creatine kinase, creatine kinase MB, and myoglobin was 9.45 hours, whereas it was 17 hours in the 14 patients in whom indirect criteria did not indicate reperfusion. Reperfusion arrhythmias were invariably present and ventricular tachycardia developed in five patients and ventricular fibrillation in two. The infarct related artery was seen to be open in 28 (70%) of the 40 patients who had delayed coronary arteriography. The frequency of patency in the infarct related artery was no different in patients given streptokinase less than 2 hours or between 2-4 hours from onset of symptoms nor did it differ when streptokinase was infused over 30 or 60 minutes. Mean left ventricular ejection fraction was 57% in those with a patient infarct related artery and 48% in those with an occluded vessel. Eight patients subsequently underwent elective percutaneous transluminal coronary angioplasty after successful thrombolysis and six had coronary artery bypass grafting. There were nine in-hospital reocclusions of the infarct related coronary arteries. Two bleeding episodes occurred; one required transfusion. Five of the 50 patients died in hospital. All of them had had an anterior myocardial infarction; four had bifascicular block and one had right bundle branch block. During follow up, four patients died, two suddenly and two from reinfarction. During follow up (mean 15 months) the frequency of reinfarction, dyspnoea, and angina was low and there was no difference in the proportions of patients returning to work between those with an open infarct related artery and those with a closed infarct related artery. Intravenous administration of high dose streptokinase to selected patients during the acute phase of myocardial infarction is a safe, effective, and practical method of thrombolysis. It must, however, be followed by coronary arteriography to select those patients in whom percutaneous transluminal coronary angioplasty or coronary artery bypass grafting will be helpful.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aber C. P., Bass N. M., Berry C. L., Carson P. H., Dobbs R. J., Fox K. M., Hamblin J. J., Haydu S. P., Howitt G., MacIver J. E. Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J. 1976 Nov 6;2(6044):1100–1104. doi: 10.1136/bmj.2.6044.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alderman E. L., Jutzy K. R., Berte L. E., Miller R. G., Friedman J. P., Creger W. P., Eliastam M. Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction. Am J Cardiol. 1984 Jul 1;54(1):14–19. doi: 10.1016/0002-9149(84)90297-2. [DOI] [PubMed] [Google Scholar]
  3. Anderson J. L., Marshall H. W., Askins J. C., Lutz J. R., Sorensen S. G., Menlove R. L., Yanowitz F. G., Hagan A. D. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation. 1984 Oct;70(4):606–618. doi: 10.1161/01.cir.70.4.606. [DOI] [PubMed] [Google Scholar]
  4. Been M., de Bono D. P., Muir A. L., Boulton F. E., Hillis W. S., Hornung R. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J. 1985 Mar;53(3):253–259. doi: 10.1136/hrt.53.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bertrand M. E., Lefebvre J. M., Laisne C. L., Rousseau M. F., Carre A. G., Lekieffre J. P. Coronary arteriography in acute transmural myocardial infarction. Am Heart J. 1979 Jan;97(1):61–69. doi: 10.1016/0002-8703(79)90115-7. [DOI] [PubMed] [Google Scholar]
  6. Braunwald E. The aggressive treatment of acute myocardial infarction. Circulation. 1985 Jun;71(6):1087–1092. doi: 10.1161/01.cir.71.6.1087. [DOI] [PubMed] [Google Scholar]
  7. Bush L. R., Buja L. M., Samowitz W., Rude R. E., Wathen M., Tilton G. D., Willerson J. T. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs. Comparison of 2- and 4-hour occlusions. Circ Res. 1983 Aug;53(2):248–263. doi: 10.1161/01.res.53.2.248. [DOI] [PubMed] [Google Scholar]
  8. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  9. Dewhurst N. G., Muir A. L. Comparative prognostic value of radionuclide ventriculography at rest and during exercise in 100 patients after first myocardial infarction. Br Heart J. 1983 Feb;49(2):111–121. doi: 10.1136/hrt.49.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ganz W., Geft I., Shah P. K., Lew A. S., Rodriguez L., Weiss T., Maddahi J., Berman D. S., Charuzi Y., Swan H. J. Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol. 1984 May 1;53(9):1209–1216. doi: 10.1016/0002-9149(84)90066-3. [DOI] [PubMed] [Google Scholar]
  11. Goldberg S., Greenspon A. J., Urban P. L., Muza B., Berger B., Walinsky P., Maroko P. R. Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J. 1983 Jan;105(1):26–32. doi: 10.1016/0002-8703(83)90274-0. [DOI] [PubMed] [Google Scholar]
  12. Harrison D. G., Ferguson D. W., Collins S. M., Skorton D. J., Ericksen E. E., Kioschos J. M., Marcus M. L., White C. W. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation. 1984 May;69(5):991–999. doi: 10.1161/01.cir.69.5.991. [DOI] [PubMed] [Google Scholar]
  13. Khaja F., Walton J. A., Jr, Brymer J. F., Lo E., Osterberger L., O'Neill W. W., Colfer H. T., Weiss R., Lee T., Kurian T. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983 Jun 2;308(22):1305–1311. doi: 10.1056/NEJM198306023082201. [DOI] [PubMed] [Google Scholar]
  14. Laffel G. L., Braunwald E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1). N Engl J Med. 1984 Sep 13;311(11):710–717. doi: 10.1056/NEJM198409133111105. [DOI] [PubMed] [Google Scholar]
  15. Laffel G. L., Braunwald E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2). N Engl J Med. 1984 Sep 20;311(12):770–776. doi: 10.1056/NEJM198409203111205. [DOI] [PubMed] [Google Scholar]
  16. Lavallee M., Cox D., Patrick T. A., Vatner S. F. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs. Circ Res. 1983 Aug;53(2):235–247. doi: 10.1161/01.res.53.2.235. [DOI] [PubMed] [Google Scholar]
  17. Markis J. E., Malagold M., Parker J. A., Silverman K. J., Barry W. H., Als A. V., Paulin S., Grossman W., Braunwald E. Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction. N Engl J Med. 1981 Oct 1;305(14):777–782. doi: 10.1056/NEJM198110013051401. [DOI] [PubMed] [Google Scholar]
  18. Mathey D. G., Kuck K. H., Tilsner V., Krebber H. J., Bleifeld W. Non surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation. 1981 Mar;63(3):489–497. doi: 10.1161/01.cir.63.3.489. [DOI] [PubMed] [Google Scholar]
  19. Mathey D. G., Rodewald G., Rentrop P., Leitz K., Merx W., Messmer B. J., Rutsch W., Bücherl E. S. Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: complementary combined approach effecting reduced infarct size, preventing reinfarction, and improving left ventricular function. Am Heart J. 1981 Dec;102(6 Pt 2):1194–1201. doi: 10.1016/0002-8703(81)90652-9. [DOI] [PubMed] [Google Scholar]
  20. Mayer G., Story W. E., Seco J. E., Nocero M. A., Jr, Shaskey D. J., Black M. A. Intravenous streptokinase in acute myocardial infarction. Ann Emerg Med. 1985 May;14(5):410–415. doi: 10.1016/s0196-0644(85)80283-3. [DOI] [PubMed] [Google Scholar]
  21. Messmer B. J., Merx W., Meyer J., Bardos P., Minale C., Effert S. New developments in medical-surgical treatment of acute myocardial infarction. Ann Thorac Surg. 1983 Jan;35(1):70–78. doi: 10.1016/s0003-4975(10)61433-6. [DOI] [PubMed] [Google Scholar]
  22. Meyer J., Merx W., Schmitz H., Erbel R., Kiesslich T., Dörr R., Lambertz H., Bethge C., Krebs W., Bardos P. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation. 1982 Nov;66(5):905–913. doi: 10.1161/01.cir.66.5.905. [DOI] [PubMed] [Google Scholar]
  23. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  24. Relman A. S. Intravenous thrombolysis in acute myocardial infarction: a progress report. N Engl J Med. 1985 Apr 4;312(14):915–916. doi: 10.1056/NEJM198504043121409. [DOI] [PubMed] [Google Scholar]
  25. Schröder R., Biamino G., von Leitner E. R., Linderer T., Brüggemann T., Heitz J., Vöhringer H. F., Wegscheider K. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation. 1983 Mar;67(3):536–548. doi: 10.1161/01.cir.67.3.536. [DOI] [PubMed] [Google Scholar]
  26. Schröder R. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Int J Cardiol. 1984 May;5(5):631–637. doi: 10.1016/0167-5273(84)90176-1. [DOI] [PubMed] [Google Scholar]
  27. Schwarz F., Schuler G., Katus H., Hofmann M., Manthey J., Tillmanns H., Mehmel H. C., Kübler W. Intracoronary thrombolysis in acute myocardial infarction: duration of ischemia as a major determinant of late results after recanalization. Am J Cardiol. 1982 Nov;50(5):933–937. doi: 10.1016/0002-9149(82)90398-8. [DOI] [PubMed] [Google Scholar]
  28. Shell W., Mickle D. K., Swan H. J. Effects of nonsurgical myocardial reperfusion on plasma creatine kinase kinetics in man. Am Heart J. 1983 Oct;106(4 Pt 1):665–669. doi: 10.1016/0002-8703(83)90084-4. [DOI] [PubMed] [Google Scholar]
  29. Silver M. D., Baroldi G., Mariani F. The relationship between acute occlusive coronary thrombi and myocardial infarction studied in 100 consecutive patients. Circulation. 1980 Feb;61(2):219–227. doi: 10.1161/01.cir.61.2.219. [DOI] [PubMed] [Google Scholar]
  30. Spann J. F., Sherry S., Carabello B. A., Denenberg B. S., Mann R. H., McCann W. D., Gault J. H., Gentzler R. D., Belber A. D., Maurer A. H. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies. Am J Cardiol. 1984 Mar 1;53(6):655–661. doi: 10.1016/0002-9149(84)90380-1. [DOI] [PubMed] [Google Scholar]
  31. Urban P. L., Cowley M., Goldberg S., Vetrovec G., Hastillo A., Greenspon A. J., Kusiak V., Greenberg R., Walinsky P., Cammarato J. Intracoronary thrombolysis in acute myocardial infarction: clinical course following successful myocardial reperfusion. Am Heart J. 1984 Oct;108(4 Pt 1):873–878. doi: 10.1016/0002-8703(84)90448-4. [DOI] [PubMed] [Google Scholar]
  32. Van de Werf F., Bergmann S. R., Fox K. A., de Geest H., Hoyng C. F., Sobel B. E., Collen D. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation. 1984 Mar;69(3):605–610. doi: 10.1161/01.cir.69.3.605. [DOI] [PubMed] [Google Scholar]
  33. Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]
  34. Verstraete M., Bleifeld W., Brower R. W., Charbonnier B., Collen D., de Bono D. P., Dunning A. J., Lennane R. J., Lubsen J., Mathey D. G. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction. Lancet. 1985 Nov 2;2(8462):965–969. doi: 10.1016/s0140-6736(85)90523-9. [DOI] [PubMed] [Google Scholar]
  35. Weinstein J. Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry. Am Heart J. 1982 Oct;104(4 Pt 2):894–898. doi: 10.1016/0002-8703(82)90262-9. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES